Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis

Annals of the Rheumatic Diseases

Volumn 73, Issue 9, 2014, Pages 1746-1748

  Turina, Maureen C ^a   Sieper, Joachim ^b   Yeremenko, Nataliya ^a   Conrad, Kristina ^b   Haibel, Hildrun ^b   Rudwaleit, Martin ^c   Baeten, Dominique ^a   Poddubnyy, Denis ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Endokrinologikum Berlin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALGRANULIN; HLA B27 ANTIGEN;

ADULT; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPINE INJURY; SPINE RADIOGRAPHY; SPONDYLARTHRITIS; SYMPTOM;

ANKYLOSING SPONDYLITIS; OUTCOMES RESEARCH; SPONDYLOARTHRITIS;

ADULT; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PROGNOSIS; SPONDYLARTHRITIS;

EID: 84905174427     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-205506     Document Type: Letter

References (9)

1. Poddubnyy D, Haibel H, Listing J, et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 2012;64:1388-98.
2. De Rycke L, Baeten D, Foell D, et al. Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis. J Pathol 2005;206:17-27. (Pubitemid 40613430)
3. Kruithof E, De Rycke L, Vandooren B, et al. Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis. Arthritis Rheum 2006;54:1795-804. (Pubitemid 43877929)
4. Madland TM, Larsen A, Brun JG. S100 proteins calprotectin and S100A12 are related to radiographic changes rather than disease activity in psoriatic arthritis with low disease activity. J Rheumatol 2007;34:2089-92. (Pubitemid 47548216)
5. Hammer HB, Odegard S, Syversen SW, et al. Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis. Ann Rheum Dis 2010;69:150-4.
6. Klingberg E, Carlsten H, Hilme E, et al. Calprotectin in ankylosing spondylitis-frequently elevated in feces, but normal in serum. Scand J Gastroenterol 2012;47:435-44.
7. Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort. Arthritis Rheum 2009;60:717-27.
8. Poddubnyy D, Rudwaleit M, Haibel H, et al. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 2012;71:1616-22.
9. Poddubnyy D, Conrad K, Haibel H, et al. Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis. Ann Rheum Dis 2013. Published Online First: 16 Aug 2013. doi:10.1136/annrheumdis-2013-203824